TRIB
NASDAQ
$0.73
Trinity Biotech Plc (TRIB)
Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments of the diagnostic market in the United States, Africa, Asia and Europe. The company is headquartered in Bray, Ireland.
Sector:
Healthcare
Industry:
Medical Devices
Target: $3 (+309.78%)
Market Cap
$13M
Free Cash Flow Yield
-31.94%
Beta (5Y)
0.94
Price Chart
Valuation
Market Cap$13M
Forward P/E4.54
P/S0.31
P/B5.75
Profitability
Total Revenue (TTM)$49M
Gross Profit (TTM)$17M
EBITDA-$16M
Profit Margin-85.4%
Operating Margin-26.6%
EPS-$2.89
Financial Health
Debt-to-Equity-191.7%
Free Cash Flow Yield-31.94%
Growth & Risk
EPS 5Y CAGR+13.50%
Revenue 5Y CAGR-11.65%
FCF 5Y CAGR-0.57%
Beta (5Y)0.94
Sharpe Ratio0.63